Skip to main content

Table 2 Multivariate analyses of predictors of poor functional outcomes

From: The association between serum adiponectin and 3-month outcome after ischemic stroke

 

OR

95% CI

P

Age (increase per unit)

1.06

1.01–1.12

0.012

Atrial fibrillation (yes vs. no)

1.39

0.97–1.76

0.13

Stroke severity, NIHSS (increase per unit)

1.08

1.03–1.14

< 0.001

Lesion volumes (increase per unit)

1.02

1.00–1.04

0.021

IV thrombolysis and/or mechanical thrombectomy (yes vs. no)

0.64

0.51–0.87

0.025

Stroke syndrome (TACS vs other)

1.62

0.65–3.87

0.49

Glucose (increase per unit)

1.19

1.05–1.30

0.015

CRP (increase per unit)

1.45

1.11–1.76

0.003

Adiponectin (increase per unit)

1.24

1.13–1.37

< 0.001

  1. Poor functional outcome was defined as an mRS > 2
  2. OR odd ratio, CI confidence interval, mRS modified Rankin Scale, NIHSS National Institutes of Health Stroke Scale, CRP C-reactive protein, TACS total anterior circulation syndrome
  3. Adjusted for significant factors which confirmed in Table 1, including age, atrial fibrillation, IV thrombolysis and/or mechanical thrombectomy, NIHSS at admission, lesion volumes, stroke syndrome, serum levels of glucose, CRP and adiponectin
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840